Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: Dose-finding clinical trials in adults and the elderly
Sharon E. Frey, Sepehr Shakib, Pornthep Chanthavanich, Peter Richmond, Timothy Smith, Terapong Tantawichien, Claudia Kittel, Peter Jaehnig, Zenaida Mojares, Bikash Verma, Niranjan Kanesa-Thasan, Matthew Hohenboken
Dive into the research topics of 'Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: Dose-finding clinical trials in adults and the elderly'. Together they form a unique fingerprint.